Figure 3.
Risk assessment of selected parameters’ values prevalence at 2nd year of diabetes therapy using laboratory data obtained at patients’ admission stage. Achievement of clinically favorable changes was based on normal ranges of selected parameters: < 1 for SDS-BMI, < 7% for HbA1c, > 7ng/ml for c-peptide. Significant results indicated with asterisks or exact p value: * - p < 0.05, ** - p < 0.01, *** - p <0.001, **** - p < 0.